CYPHERPUNK TECHNOLOGIES INC. (CYPH) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $108.00K; Additional Paid in CapitalUSD $639.62M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-81.00K; Retained Earnings (Accumulated Deficit)USD $-500.33M.
- 2026-03-31: Common Stock, Value, IssuedUSD $94.00K; Additional Paid in CapitalUSD $624.08M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-86.00K; Retained Earnings (Accumulated Deficit)USD $-539.72M.
- 2025-12-31: Common Stock, Value, IssuedUSD $84.00K; Additional Paid in CapitalUSD $616.22M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-95.00K; Retained Earnings (Accumulated Deficit)USD $-462.55M.
- 2025-09-30: Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $505.51M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-104.00K; Retained Earnings (Accumulated Deficit)USD $-502.75M.
CYPHERPUNK TECHNOLOGIES INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $108.00K | $639.62M | $-81.00K | $-500.33M | $139.32M | 3 month · $37.00K 6 month · $53.00K | 3 month · $2.16M 6 month · $4.29M | (m) |
| 2026-03-31 | $94.00K | $624.08M | $-86.00K | $-539.72M | $84.38M | (m) | 3 month · $2.13M | (m) |
| 2025-12-31 | $84.00K | $616.22M | $-95.00K | $-462.55M | $153.51M | (m) | 12 month · $4.90M | (m) |
| 2025-09-30 | $41.00K | $505.51M | $-104.00K | $-502.75M | $2.69M | (m) | 3 month · $303.00K 9 month · $3.00M | (m) |
| 2025-06-30 | $41.00K | $505.21M | $-82.00K | $-499.45M | $5.72M | (m) | 3 month · $1.49M 6 month · $2.69M | (m) |
| 2025-03-31 | $41.00K | $503.72M | $-113.00K | $-482.81M | $20.84M | (m) | 3 month · $1.20M | (m) |
| 2024-12-31 | $38.00K | $502.50M | $-120.00K | $-467.37M | $35.05M | (m) | 12 month · $5.50M | (m) |
| 2024-09-30 | $38.00K | $500.85M | $6.00K | $-451.94M | $48.95M | (m) | 3 month · $1.34M 9 month · $3.96M | (m) |
| 2024-06-30 | $38.00K | $499.51M | $3.00K | $-433.76M | $65.79M | (m) | 3 month · $1.37M 6 month · $2.62M | (m) |
| 2024-03-31 | $26.00K | $460.87M | $-120.00K | $-413.40M | $47.37M | (m) | 3 month · $1.25M | (m) |
| 2023-12-31 | $26.00K | $459.59M | $106.00K | $-399.58M | $60.14M | (m) | 12 month · $5.13M | 12 month · $13.00K |
| 2023-09-30 | $26.00K | $458.34M | $760.00K | $-387.12M | $72.01M | (m) | 3 month · $1.30M 9 month · $3.88M | 9 month · $13.00K |
| 2023-06-30 | $26.00K | $457.04M | $414.00K | $-373.42M | $84.06M | (m) | 3 month · $1.26M 6 month · $2.58M | 6 month · $13.00K |
| 2023-03-31 | $119.00K | $387.89M | $355.00K | $-360.03M | $28.33M | (m) | 3 month · $1.31M | 3 month · $13.00K |
| 2022-12-31 | $10.00K | $376.90M | $128.00K | $-318.17M | $58.87M | (m) | 12 month · $5.18M | (m) |
| 2022-09-30 | $99.00K | $375.35M | $690.00K | $-306.07M | $70.07M | (m) | 3 month · $1.25M 9 month · $3.72M | (m) |
| 2022-06-30 | $88.00K | $374.11M | $94.00K | $-290.97M | $83.32M | (m) | 3 month · $1.27M 6 month · $2.47M | (m) |
| 2022-03-31 | $88.00K | $372.84M | $-425.00K | $-273.95M | $98.56M | (m) | 3 month · $1.20M | (m) |
| 2021-12-31 | $88.00K | $371.64M | $-267.00K | $-263.57M | $107.89M | 12 month · $6.73M | 12 month · $3.69M | (m) |
| 2021-09-30 | $88.00K | $369.76M | $-246.00K | $-252.78M | $116.82M | (m) | 3 month · $1.00M 9 month · $2.75M | (m) |
| 2021-06-30 | $60.00K | $271.92M | $-449.00K | $-241.65M | $29.88M | (m) | 3 month · $912.00K 6 month · $1.75M | (m) |
| 2021-03-31 | $60.00K | $271.00M | $-564.00K | $-232.12M | $38.38M | (m) | 3 month · $833.00K | (m) |
| 2020-12-31 | $60.00K | $270.15M | $-579.00K | $-222.99M | $46.65M | (m) | 12 month · $2.57M | (m) |
| 2020-09-30 | $60.00K | $269.44M | $-87.00K | $-216.28M | $53.14M | (m) | 3 month · $670.00K 9 month · $1.86M | (m) |
| 2020-06-30 | $60.00K | $268.77M | $121.00K | $-209.22M | $59.73M | (m) | 3 month · $617.00K 6 month · $1.19M | (m) |
| 2020-03-31 | $36.00K | $219.64M | $988.00K | $-202.70M | $17.96M | 3 month · $1.66M | 3 month · $570.00K | (m) |
| 2019-12-31 | $24.00K | $193.32M | $76.00K | $-195.17M | $-1.75M | (m) | 12 month · $3.73M | (m) |
| 2019-09-30 | $24.00K | $192.38M | $327.00K | $-187.17M | $5.56M | (m) | 3 month · $950.00K 9 month · $2.80M | (m) |
| 2019-06-30 | $23.00K | $189.83M | $322.00K | $-179.24M | $10.94M | (m) | 3 month · $899.00K 6 month · $1.85M | (m) |
| 2019-03-31 | $22.00K | $187.63M | $278.00K | $-170.87M | $17.06M | 3 month · $1.10M | 3 month · $947.00K | (m) |
| 2018-12-31 | $15.00K | $162.39M | $302.00K | $-153.53M | $9.18M | (m) | 12 month · $3.47M | (m) |
| 2018-09-30 | $15.00K | $161.47M | $160.00K | $-155.01M | $6.63M | 9 month · $1.30M | 3 month · $932.00K 9 month · $2.54M | (m) |
| 2018-06-30 | $15.00K | $160.52M | $-19.00K | $-148.38M | $12.13M | 6 month · $1.30M | 3 month · $885.00K 6 month · $1.61M | (m) |
| 2018-03-31 | $15.00K | $157.29M | $-158.00K | $-141.02M | $16.13M | 3 month · $1.30M | 3 month · $728.00K | (m) |
| 2017-12-31 | $12.00K | $141.77M | $-268.00K | $-130.40M | $11.12M | (m) | 12 month · $5.60M | (m) |
| 2017-09-30 | $9.00K | $135.65M | $-269.00K | $-123.80M | $11.59M | 9 month · $947.00K | 9 month · $4.91M | (m) |
| 2017-06-30 | $9.00K | $135.00M | $331.00K | $-116.99M | $18.35M | 6 month · $947.00K | 6 month · $4.26M | (m) |
| 2017-03-31 | $9.00K | $134.35M | $-105.00K | $-110.08M | $24.17M | 3 month · $947.00K | 3 month · $3.62M | (m) |
| 2016-12-31 | (m) | $145.00K | $294.00K | $-100.67M | $-100.23M | (m) | 12 month · $45.00K | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | $-70.29M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |